Triamterene And Hydrochlorothiazide Tablet
Product Images NDC 51655-582

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Triamterene And Hydrochlorothiazide (NDC 51655-582). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 582 52)

Triamterene and Hydrochlorothiazide Tablets, USP 75 mg / 50 mg oral tablets in a 30 tablet package. The label includes storage instructions, prescription status, and repackaging information by Northwind Pharmaceuticals.*

FDA Label Image

Structure-hydrochlorothiazide (Structure Hydrochlorothiazide)

Chemical structure of Triamterene and Hydrochlorothiazide showing a detailed molecular diagram with atoms and bonds, along with the molecular formula C7H8ClN8O4S2 and molecular weight 297.73.*

FDA Label Image

Structure-triamterene (Structure Triamterene)

Chemical structure of the active ingredient Triamterene, depicted with its molecular formula C12H11N7 and a molecular weight of 253.27, shown as a 2D line drawing highlighting its heterocyclic and amino group components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.